|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:COMMD10-CHSY3 (FusionGDB2 ID:18504) |
Fusion Gene Summary for COMMD10-CHSY3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: COMMD10-CHSY3 | Fusion gene ID: 18504 | Hgene | Tgene | Gene symbol | COMMD10 | CHSY3 | Gene ID | 51397 | 337876 |
| Gene name | COMM domain containing 10 | chondroitin sulfate synthase 3 | |
| Synonyms | PTD002 | CHSY2|CSS3 | |
| Cytomap | 5q23.1 | 5q23.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | COMM domain-containing protein 10 | chondroitin sulfate synthase 3N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3N-acetylgalactosaminyltransferase 3carbohydrate synthase 2chSy-2chondroitin glucuronyltransferase 3chondroitin synthase-2glucuronosyl-N-acetylgalactos | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9Y6G5 | Q70JA7 | |
| Ensembl transtripts involved in fusion gene | ENST00000274458, ENST00000515539, ENST00000503424, | ENST00000507545, ENST00000305031, | |
| Fusion gene scores | * DoF score | 11 X 9 X 8=792 | 6 X 6 X 2=72 |
| # samples | 15 | 6 | |
| ** MAII score | log2(15/792*10)=-2.40053792958373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/72*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: COMMD10 [Title/Abstract] AND CHSY3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | COMMD10(115469875)-CHSY3(129519922), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across COMMD10 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CHSY3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-XX-A899-01A | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + |
Top |
Fusion Gene ORF analysis for COMMD10-CHSY3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-3UTR | ENST00000274458 | ENST00000507545 | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + |
| 5CDS-3UTR | ENST00000515539 | ENST00000507545 | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + |
| In-frame | ENST00000274458 | ENST00000305031 | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + |
| In-frame | ENST00000515539 | ENST00000305031 | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + |
| intron-3CDS | ENST00000503424 | ENST00000305031 | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + |
| intron-3UTR | ENST00000503424 | ENST00000507545 | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000274458 | COMMD10 | chr5 | 115469875 | + | ENST00000305031 | CHSY3 | chr5 | 129519922 | + | 2978 | 572 | 14 | 2134 | 706 |
| ENST00000515539 | COMMD10 | chr5 | 115469875 | + | ENST00000305031 | CHSY3 | chr5 | 129519922 | + | 3008 | 602 | 134 | 2164 | 676 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000274458 | ENST00000305031 | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + | 0.001430816 | 0.99856913 |
| ENST00000515539 | ENST00000305031 | COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519922 | + | 0.002571516 | 0.9974285 |
Top |
Fusion Genomic Features for COMMD10-CHSY3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519921 | + | 2.69E-06 | 0.99999726 |
| COMMD10 | chr5 | 115469875 | + | CHSY3 | chr5 | 129519921 | + | 2.69E-06 | 0.99999726 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for COMMD10-CHSY3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:115469875/chr5:129519922) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| COMMD10 | CHSY3 |
| FUNCTION: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). {ECO:0000269|PubMed:15799966, ECO:0000305|PubMed:21778237}. | FUNCTION: Has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Specific activity is much reduced compared to CHSY1. {ECO:0000269|PubMed:12907687}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | CHSY3 | chr5:115469875 | chr5:129519922 | ENST00000305031 | 1 | 3 | 539_544 | 362 | 883.0 | Compositional bias | Note=Poly-Leu |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | COMMD10 | chr5:115469875 | chr5:129519922 | ENST00000274458 | + | 5 | 7 | 133_202 | 170 | 203.0 | Domain | COMM |
| Tgene | CHSY3 | chr5:115469875 | chr5:129519922 | ENST00000305031 | 1 | 3 | 211_235 | 362 | 883.0 | Compositional bias | Note=Pro-rich | |
| Tgene | CHSY3 | chr5:115469875 | chr5:129519922 | ENST00000305031 | 1 | 3 | 1_7 | 362 | 883.0 | Topological domain | Cytoplasmic | |
| Tgene | CHSY3 | chr5:115469875 | chr5:129519922 | ENST00000305031 | 1 | 3 | 29_882 | 362 | 883.0 | Topological domain | Lumenal | |
| Tgene | CHSY3 | chr5:115469875 | chr5:129519922 | ENST00000305031 | 1 | 3 | 8_28 | 362 | 883.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Top |
Fusion Gene Sequence for COMMD10-CHSY3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >18504_18504_1_COMMD10-CHSY3_COMMD10_chr5_115469875_ENST00000274458_CHSY3_chr5_129519922_ENST00000305031_length(transcript)=2978nt_BP=572nt GCGGCCGCCATTGGCTGGGTTCGGCGCAGCTAACAGACGGCGGCAGTGCGAGAAAGCCGAAGATGGCGGTCCCCGCGGCGCTGATCCTAC GGGAGAGCCCCAGCATGAAGAAAGCAGTGTCACTGATAAATGCAATAGATACAGGAAGATTTCCACGGTTGCTCACTCGGATTCTTCAAA AACTTCACCTGAAGGCTGAGAGCAGTTTCAGTGAAGAAGAGGAAGAAAAACTTCAAGCGGCATTTTCTCTAGAGAAACAAGATCTTCACC TAGTTCTTGAAACAATATCATTTATTTTAGAACAGGCAGTGTATCACAATGTGAAGCCAGCAGCTTTGCAGCAGCAATTAGAGAACATTC ATCTTAGACAAGACAAAGCTGAAGCATTTGTCAATACGTGGTCTTCTATGGGTCAAGAAACAGTTGAAAAGTTCCGGCAGAGAATTCTGG CTCCCTGTAAGCTAGAGACCGTTGGATGGCAGCTTAACCTTCAGATGGCTCACTCTGCTCAAGCAAAACTAAAATCTCCTCAAGCTGTGT TACAACTCGGAGTGAACAATGAAGATTCAAAGATGCAACAACTGTTCCATGAAAATTATGAACACAATCGGAAGGGTTACATCCAAGACC TTCACAATAGCAAAATCCATGCAGCCATAACACTTCATCCCAACAAAAGGCCTGCATACCAATACAGGCTGCATAATTACATGCTCAGCC GCAAAATTTCTGAACTTCGCTACCGCACCATCCAGCTCCACAGGGAAAGTGCCCTGATGAGCAAGCTCAGTAACACAGAAGTGAGCAAAG AGGACCAGCAGCTGGGAGTGATACCTTCTTTCAACCACTTCCAGCCTCGGGAGAGAAATGAAGTGATAGAATGGGAGTTCCTGACAGGGA AGCTTCTATACTCAGCAGCTGAGAACCAGCCCCCTCGACAGAGCCTCAGTAGCATTTTAAGAACAGCACTGGATGATACCGTCCTACAGG TGATGGAGATGATCAATGAGAATGCCAAGAGCAGAGGACGGCTCATTGACTTCAAGGAAATTCAGTATGGCTACCGCAGAGTTAACCCCA TGCACGGGGTGGAGTACATTTTGGATTTACTCCTTTTATACAAAAGACACAAGGGAAGGAAACTGACTGTGCCAGTGAGACGTCATGCCT ATCTTCAGCAGTTGTTCAGCAAGCCTTTCTTCAGAGAGACCGAAGAGCTAGATGTCAACAGTCTTGTGGAGAGTATTAACAGTGAAACTC AGTCATTCTCCTTTATATCTAATTCTTTAAAGATATTATCTTCTTTTCAAGGTGCCAAAGAAATGGGAGGGCACAATGAAAAGAAAGTAC ACATTCTCGTTCCTCTCATCGGAAGGTATGACATTTTCTTGAGATTCATGGAGAACTTTGAAAACATGTGTCTTATCCCAAAGCAGAATG TAAAGTTGGTCATTATCCTTTTCAGTAGGGATTCTGGCCAAGACTCCAGCAAGCATATTGAGCTGATAAAAGGGTACCAGAACAAGTACC CCAAAGCAGAAATGACCCTGATCCCAATGAAGGGAGAGTTTTCCAGAGGTCTTGGTCTTGAAATGGCTTCTGCCCAGTTTGACAATGACA CTTTGCTGCTATTTTGTGATGTTGACTTGATCTTCAGAGAAGATTTTCTCCAACGATGTAGAGACAATACAATTCAGGGACAACAGGTGT ACTATCCCATCATCTTTAGCCAGTATGACCCAAAGGTAACAAACGGGGGAAATCCTCCCACTGATGATTACTTCATATTCTCAAAAAAGA CTGGATTTTGGAGAGACTATGGATATGGCATCACCTGTATTTACAAAAGTGATCTTCTAGGTGCAGGTGGATTTGATACCTCAATACAAG GCTGGGGACTAGAAGATGTAGATCTCTACAATAAAGTCATTCTATCTGGCTTAAGGCCATTCAGAAGCCAAGAAGTAGGAGTGGTGCATA TTTTCCATCCAGTTCATTGTGATCCTAACTTGGACCCTAAGCAGTATAAGATGTGCTTAGGATCCAAGGCAAGTACTTTCGCCTCAACCA TGCAACTGGCTGAACTCTGGCTTGAAAAACATTTAGGTGTCAGGTACAATCGAACTCTCTCCTGACAGTCCAGGCAACACATTTTGCCTT TTTTAAGGGGAGTTTACCTCATTGTTGGTTGTTGTTATTTTTATTGTATTATTGTTATTTTATTATTATTATTGTTATAATTTTATTTTG TTGTCCTGGTCTTAAACTACTCTTGGTTGTCTTCCTAAGGGTGTTTGTTGACCTCAAGCAAGAAGAGTCTGCAGTTCACTGATGTTTCAG ATTTCTACTGAAGTCAATATGTTATTACTTTTATATAACTTTATTTGAGATTGAGTTAAATCATAGCAATCAAATGACTTTTGAAACGCA TTCATCACAAGAGACAGCTTAGAAGAATGTTCTCTTGGGGCTTAAAGATGCAATATCGACTTTTATTTGGTTTCTCAAATTCAATGTGAT ACAAATATTTACTGGTGAAAGGTACCACAAAAGTGCTTTATGCTTCCTATGGGGAAGGGACTCTGTAACATAAACTTGAGTTTTGTAATT TATACAAGGACTTAAATATATAAACAATAATTTTCTTCATCTTTAGAATTTTTAAAGTAAATGAATACCTATGATTGTATGTTTATTTTT TAAAAAAAGTTTTAAAAATTGAGGAGTTTTGTTCCACAAGCAACCGGTACTGGCTACCCTGGTCTTATGACAATTATGAGCTCCTCACAA CTGTCTGCTATAAATGCGAATGAACTTTATTTTCTCAAGGAAATATGATTTAATTAAATATTCATGTACATTTTAGAAGCTTTATGAAAC AATGTCCTTCATTTGCTGGCAAGAAGATAAAATATGACAGAACCTGTTTATTTAAAATAAAACACAGGTATAGCAGTATTCTTTTTCAAA >18504_18504_1_COMMD10-CHSY3_COMMD10_chr5_115469875_ENST00000274458_CHSY3_chr5_129519922_ENST00000305031_length(amino acids)=706AA_BP=186 MGSAQLTDGGSARKPKMAVPAALILRESPSMKKAVSLINAIDTGRFPRLLTRILQKLHLKAESSFSEEEEEKLQAAFSLEKQDLHLVLET ISFILEQAVYHNVKPAALQQQLENIHLRQDKAEAFVNTWSSMGQETVEKFRQRILAPCKLETVGWQLNLQMAHSAQAKLKSPQAVLQLGV NNEDSKMQQLFHENYEHNRKGYIQDLHNSKIHAAITLHPNKRPAYQYRLHNYMLSRKISELRYRTIQLHRESALMSKLSNTEVSKEDQQL GVIPSFNHFQPRERNEVIEWEFLTGKLLYSAAENQPPRQSLSSILRTALDDTVLQVMEMINENAKSRGRLIDFKEIQYGYRRVNPMHGVE YILDLLLLYKRHKGRKLTVPVRRHAYLQQLFSKPFFRETEELDVNSLVESINSETQSFSFISNSLKILSSFQGAKEMGGHNEKKVHILVP LIGRYDIFLRFMENFENMCLIPKQNVKLVIILFSRDSGQDSSKHIELIKGYQNKYPKAEMTLIPMKGEFSRGLGLEMASAQFDNDTLLLF CDVDLIFREDFLQRCRDNTIQGQQVYYPIIFSQYDPKVTNGGNPPTDDYFIFSKKTGFWRDYGYGITCIYKSDLLGAGGFDTSIQGWGLE -------------------------------------------------------------- >18504_18504_2_COMMD10-CHSY3_COMMD10_chr5_115469875_ENST00000515539_CHSY3_chr5_129519922_ENST00000305031_length(transcript)=3008nt_BP=602nt GACACTCTGGTGGGAAAGGCTCACGCTGCTGCTGGAGGGTCTTTAATAGCCAACATGTGTTAATACCCCTTTTAAATCAGTATCGAATAG GGGACCGAATTTTTGGTTGGTAGAAGAATCTAGCCTGGCTTTGCATGAAGAAAGCAGTGTCACTGATAAATGCAATAGATACAGGAAGAT TTCCACGGTTGCTCACTCGGATTCTTCAAAAACTTCACCTGAAGGCTGAGAGCAGTTTCAGTGAAGAAGAGGAAGAAAAACTTCAAGCGG CATTTTCTCTAGAGAAACAAGATCTTCACCTAGTTCTTGAAACAATATCATTTATTTTAGAACAGGCAGTGTATCACAATGTGAAGCCAG CAGCTTTGCAGCAGCAATTAGAGAACATTCATCTTAGACAAGACAAAGCTGAAGCATTTGTCAATACGTGGTCTTCTATGGGTCAAGAAA CAGTTGAAAAGTTCCGGCAGAGAATTCTGGCTCCCTGTAAGCTAGAGACCGTTGGATGGCAGCTTAACCTTCAGATGGCTCACTCTGCTC AAGCAAAACTAAAATCTCCTCAAGCTGTGTTACAACTCGGAGTGAACAATGAAGATTCAAAGATGCAACAACTGTTCCATGAAAATTATG AACACAATCGGAAGGGTTACATCCAAGACCTTCACAATAGCAAAATCCATGCAGCCATAACACTTCATCCCAACAAAAGGCCTGCATACC AATACAGGCTGCATAATTACATGCTCAGCCGCAAAATTTCTGAACTTCGCTACCGCACCATCCAGCTCCACAGGGAAAGTGCCCTGATGA GCAAGCTCAGTAACACAGAAGTGAGCAAAGAGGACCAGCAGCTGGGAGTGATACCTTCTTTCAACCACTTCCAGCCTCGGGAGAGAAATG AAGTGATAGAATGGGAGTTCCTGACAGGGAAGCTTCTATACTCAGCAGCTGAGAACCAGCCCCCTCGACAGAGCCTCAGTAGCATTTTAA GAACAGCACTGGATGATACCGTCCTACAGGTGATGGAGATGATCAATGAGAATGCCAAGAGCAGAGGACGGCTCATTGACTTCAAGGAAA TTCAGTATGGCTACCGCAGAGTTAACCCCATGCACGGGGTGGAGTACATTTTGGATTTACTCCTTTTATACAAAAGACACAAGGGAAGGA AACTGACTGTGCCAGTGAGACGTCATGCCTATCTTCAGCAGTTGTTCAGCAAGCCTTTCTTCAGAGAGACCGAAGAGCTAGATGTCAACA GTCTTGTGGAGAGTATTAACAGTGAAACTCAGTCATTCTCCTTTATATCTAATTCTTTAAAGATATTATCTTCTTTTCAAGGTGCCAAAG AAATGGGAGGGCACAATGAAAAGAAAGTACACATTCTCGTTCCTCTCATCGGAAGGTATGACATTTTCTTGAGATTCATGGAGAACTTTG AAAACATGTGTCTTATCCCAAAGCAGAATGTAAAGTTGGTCATTATCCTTTTCAGTAGGGATTCTGGCCAAGACTCCAGCAAGCATATTG AGCTGATAAAAGGGTACCAGAACAAGTACCCCAAAGCAGAAATGACCCTGATCCCAATGAAGGGAGAGTTTTCCAGAGGTCTTGGTCTTG AAATGGCTTCTGCCCAGTTTGACAATGACACTTTGCTGCTATTTTGTGATGTTGACTTGATCTTCAGAGAAGATTTTCTCCAACGATGTA GAGACAATACAATTCAGGGACAACAGGTGTACTATCCCATCATCTTTAGCCAGTATGACCCAAAGGTAACAAACGGGGGAAATCCTCCCA CTGATGATTACTTCATATTCTCAAAAAAGACTGGATTTTGGAGAGACTATGGATATGGCATCACCTGTATTTACAAAAGTGATCTTCTAG GTGCAGGTGGATTTGATACCTCAATACAAGGCTGGGGACTAGAAGATGTAGATCTCTACAATAAAGTCATTCTATCTGGCTTAAGGCCAT TCAGAAGCCAAGAAGTAGGAGTGGTGCATATTTTCCATCCAGTTCATTGTGATCCTAACTTGGACCCTAAGCAGTATAAGATGTGCTTAG GATCCAAGGCAAGTACTTTCGCCTCAACCATGCAACTGGCTGAACTCTGGCTTGAAAAACATTTAGGTGTCAGGTACAATCGAACTCTCT CCTGACAGTCCAGGCAACACATTTTGCCTTTTTTAAGGGGAGTTTACCTCATTGTTGGTTGTTGTTATTTTTATTGTATTATTGTTATTT TATTATTATTATTGTTATAATTTTATTTTGTTGTCCTGGTCTTAAACTACTCTTGGTTGTCTTCCTAAGGGTGTTTGTTGACCTCAAGCA AGAAGAGTCTGCAGTTCACTGATGTTTCAGATTTCTACTGAAGTCAATATGTTATTACTTTTATATAACTTTATTTGAGATTGAGTTAAA TCATAGCAATCAAATGACTTTTGAAACGCATTCATCACAAGAGACAGCTTAGAAGAATGTTCTCTTGGGGCTTAAAGATGCAATATCGAC TTTTATTTGGTTTCTCAAATTCAATGTGATACAAATATTTACTGGTGAAAGGTACCACAAAAGTGCTTTATGCTTCCTATGGGGAAGGGA CTCTGTAACATAAACTTGAGTTTTGTAATTTATACAAGGACTTAAATATATAAACAATAATTTTCTTCATCTTTAGAATTTTTAAAGTAA ATGAATACCTATGATTGTATGTTTATTTTTTAAAAAAAGTTTTAAAAATTGAGGAGTTTTGTTCCACAAGCAACCGGTACTGGCTACCCT GGTCTTATGACAATTATGAGCTCCTCACAACTGTCTGCTATAAATGCGAATGAACTTTATTTTCTCAAGGAAATATGATTTAATTAAATA TTCATGTACATTTTAGAAGCTTTATGAAACAATGTCCTTCATTTGCTGGCAAGAAGATAAAATATGACAGAACCTGTTTATTTAAAATAA >18504_18504_2_COMMD10-CHSY3_COMMD10_chr5_115469875_ENST00000515539_CHSY3_chr5_129519922_ENST00000305031_length(amino acids)=676AA_BP=156 MKKAVSLINAIDTGRFPRLLTRILQKLHLKAESSFSEEEEEKLQAAFSLEKQDLHLVLETISFILEQAVYHNVKPAALQQQLENIHLRQD KAEAFVNTWSSMGQETVEKFRQRILAPCKLETVGWQLNLQMAHSAQAKLKSPQAVLQLGVNNEDSKMQQLFHENYEHNRKGYIQDLHNSK IHAAITLHPNKRPAYQYRLHNYMLSRKISELRYRTIQLHRESALMSKLSNTEVSKEDQQLGVIPSFNHFQPRERNEVIEWEFLTGKLLYS AAENQPPRQSLSSILRTALDDTVLQVMEMINENAKSRGRLIDFKEIQYGYRRVNPMHGVEYILDLLLLYKRHKGRKLTVPVRRHAYLQQL FSKPFFRETEELDVNSLVESINSETQSFSFISNSLKILSSFQGAKEMGGHNEKKVHILVPLIGRYDIFLRFMENFENMCLIPKQNVKLVI ILFSRDSGQDSSKHIELIKGYQNKYPKAEMTLIPMKGEFSRGLGLEMASAQFDNDTLLLFCDVDLIFREDFLQRCRDNTIQGQQVYYPII FSQYDPKVTNGGNPPTDDYFIFSKKTGFWRDYGYGITCIYKSDLLGAGGFDTSIQGWGLEDVDLYNKVILSGLRPFRSQEVGVVHIFHPV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for COMMD10-CHSY3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for COMMD10-CHSY3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for COMMD10-CHSY3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies